In preclinical models of human hepatocellular carcinoma, high LOXL4 expressing macrophages have an immunosuppressive function via an interferon (IFN)-mediated signal transducer and activator of the transcription (STATs)-dependent PD-L1 activation on CD8+ T cells [193]. Here, LOXL4 is linked to hepatocellular carcinoma.